Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
about
Serum Survivin Levels and Outcome of Chemotherapy in Patients with Malignant Mesothelioma.Diagnostic and prognostic utilities of humoral fibulin-3 in malignant pleural mesothelioma: Evidence from a meta-analysis.Plasma Fibulin-3 as a Potential Biomarker for Patients with Asbestos-Related Diseases in the Han Population.Serum mesothelin and other biomarkers: what have we learned in the last decade?Evaluation of New Biomarkers in the Prediction of Malignant Mesothelioma in Subjects with Environmental Asbestos Exposure.Biomarkers for Early Diagnosis and Prognosis of Malignant Pleural Mesothelioma: The Quest Goes on.
P2860
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
description
2015 nî lūn-bûn
@nan
2015 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@ast
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@en
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@nl
type
label
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@ast
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@en
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@nl
prefLabel
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@ast
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@en
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@nl
P2093
P2860
P356
P1476
Fibulin-3 as a biomarker of response to treatment in malignant mesothelioma
@en
P2093
Alenka Franko
Metoda Dodic-Fikfak
Niko Arneric
Viljem Kovac
Vita Dolzan
P2860
P304
P356
10.1515/RAON-2015-0019
P407
P577
2015-09-01T00:00:00Z